We next examined the specificity of GroA treatment toward cancer cells, and found that it reduces the viability of SKBR3 human breast cancer cell lines, but has virtually no effect in the non-cancerous, human breast tissue cell line, MCF10A (Fig. 3b, right). The gene discussed is CXCL1; the disease is cancer.